RA
NSPR icon

Rosalind Advisors’s InspireMD NSPR Stock Holding History

Rosalind Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.37M Hold
3,905,743
– – 2.56% 15
2025
Q4 		$6.95M Hold
3,905,743
– – 2.44% 17
2025
Q3 		$9.41M Buy
3,905,743
+1,616,644
+71% +$3.92M 3.22% 13
2025
Q2 		$5.2M Buy
2,289,099
+14,109
+0.6% +$35.2K 2.46% 17
2025
Q1 		$6.12M Sell
2,274,990
-220,793
-9% -$625K 2.98% 15
2024
Q4 		$6.56M Sell
2,495,783
-18,263
-0.7% -$49.1K 3.36% 13
2024
Q3 		$6.74M Buy
2,514,046
+405
+0% +$1.1K 4.31% 11
2024
Q2 		$6.27M Buy
2,513,641
+1,827,579
+266% +$4.28M 4.83% 8
2024
Q1 		$1.63M Sell
686,062
-239,132
-26% -$645K 1.52% 21
2023
Q4 		$2.6M Buy
+925,194
New +$2.66M 2.14% 18

Other funds holding NSPR

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Rosalind Advisors's NSPR Position: Q1 2026 in Review

Rosalind Advisors held its InspireMD (NSPR) position steady in Q1 2026 at 3,905,743 shares worth $6.37M. The position accounts for 2.56% of the portfolio, ranked #15.

Rosalind Advisors first reported a position in NSPR in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.41M in Q3 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Rosalind Advisors held 3,905,743 shares of InspireMD worth $6.37M as of Q1 2026.
  • Rosalind Advisors left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up 2.56% of Rosalind Advisors's portfolio in Q1 2026, its #15 holding.
  • Rosalind Advisors first reported a position in InspireMD in Q4 2023 and has held it in 10 quarters since.
  • Rosalind Advisors's InspireMD position peaked at $9.41M in Q3 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Rosalind Advisors's 13F filing for Q1 2026, filed 14 May 2026.